MSS CRC

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

MSS CRC
Jun 28, 2024, 13:48 | Insight
Arndt Vogel: Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at ESMOGI24
Arndt Vogel shared on X: "Neoadjuvant botensilimab + balstilimab in MSI and MSS CRC at…
Jun 28, 2024, 13:41 | Insight
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Agenus shared on their X page: "New data from the NEST clinical trial was presented…
Jun 28, 2024, 13:09 | Insight
Vittorio Studiale: Impressive pathological response rate with neoadjuvant BOT/BAL in MSS CRC
Vittorio Studiale, Medical Oncology Resident at University Hospital of Pisa, shared on X: "Impressive pathological…
Jun 15, 2024, 02:09 | Insight
Anthony El-Khoueiry: Botensilimab with expansion in MSS CRC; activity noted across multiple cold tumors
Anthony El-Khoueiry, Associate Professor of Medicine at University of Southern California Norris Comprehensive Cancer Center,…
Apr 17, 2024, 17:16 | Insight
Rafeh Naqash: Fantastic discussion on biomarker testing and precison oncology
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, replied to the post of Rafeh…
Apr 13, 2024, 15:16 | Blog
Zack Armen: This is incredibly exciting for patients with neoadjuvant colon and rectal cancer
Zack Armen, Head of Investor Relations at Agenus, shared a post by Pashtoon Kasi, Oncologist…
Apr 13, 2024, 15:11 | Insight
Pashtoon Kasi: BOT/BAL we are at our 12+ patients with MSS colorectal cancer within weeks
Pashtoon Kasi, Oncologist and Researcher at Weill Cornell Medicine, shared a post on X/Twitter: ''We have…
Feb 7, 2024, 05:45 | Insight
Deniz Can Guven: Our systematic review on microsatellite stable colorectal cancer is out
Deniz Can Guven, Medical Oncologist at Health Sciences University, shared on X/Twitter: "Our systematic review…
All: 8 Posts: 1 - 100
Special Coverage